[144] Saba Capital Income & Opportunities Fund II SEC Filing

Rhea-AI Filing Summary

The Form 144 shows an investor-affiliated sale notice for Common shares of the issuer associated with SABA. The filer reports an intended sale of 258,287 shares (approximate aggregate market value $2,396,903.36) through multiple broker-dealers on 09/08/2025 on the NYSE. These shares were acquired on 01/22/2018 in open-market purchases and were paid in cash. The filing also lists prior sales by the same account in the past three months: 21,563 shares on 06/16/2025, 6,250 shares on 06/17/2025, and 22,029 shares on 09/08/2025, with gross proceeds shown for each transaction.

Positive

• Full disclosure of planned sale: The filer provides the required Rule 144 notice including share count, aggregate market value, brokers, and sale date.
• Acquisition details included: The filing states the shares were acquired on 01/22/2018 in open-market purchases and paid in cash.
• Recent transaction history provided: The document lists prior sales on 06/16/2025, 06/17/2025, and 09/08/2025 with gross proceeds.

Negative

• Proposed large sale: A planned disposition of 258,287 shares is scheduled for 09/08/2025 which could increase share supply on the NYSE.
• Ongoing disposals: The filer sold 21,563 shares on 06/16/2025 and 6,250 shares on 06/17/2025, plus 22,029 shares listed for 09/08/2025, indicating continued selling activity.

Insights

Securities Analyst

TL;DR Large-block sale notice by an investment manager; shares acquired in 2018 and scheduled for sale across several dealers on 09/08/2025.

The filing is a routine Rule 144 notice disclosing a proposed open-market disposition of 258,287 common shares with an indicated aggregate market value of $2,396,903.36, to be executed through multiple broker-dealers on the NYSE. Acquisition details state the position was built via open-market purchases on 01/22/2018 and paid in cash. The document also records recent liquidity activity by the same account with specific sale dates and gross proceeds, providing transparent transaction history required by securities rules.

Compliance/Risk Analyst

TL;DR Filing meets disclosure requirements; shows prior and planned disposals that may be relevant for market transparency and monitoring.

The notice includes the mandatory representation that no undisclosed material adverse information is known to the seller and identifies execution through a list of broker-dealers. Payment and acquisition fields indicate cash purchases and no gifts. The inclusion of recent sales in June and September 2025 supplies a short track record of disposition activity that compliance teams can use to confirm aggregation and Rule 144 holdings limits.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Capital Markets 155 Seaport Boulevard Boston MA 02210	258287	2396903.36	27716010	09/08/2025	NYSE
Common	FBN Securities 120 Broadway New York NY 10271	258287	2396903.36	27716010	09/08/2025	NYSE
Common	Barclays Bank PLC One Churchill Place, Canary Wharf London X0 E14 5HP	258287	2396903.36	27716010	09/08/2025	NYSE
Common	BTIG, LLC 350 Bush Street San Francisco CA 94104	258287	2396903.36	27716010	09/08/2025	NYSE
Common	CIBC Capital Markets 1 Battery Pl #10 New York NY 10014	258287	2396903.36	27716010	09/08/2025	NYSE
Common	Goldman Sachs & Co 200 West Street New York NY 10282	258287	2396903.36	27716010	09/08/2025	NYSE
Common	Northern Trust Corporation 50 South La Salle Street Chicago IL 60603	258287	2396903.36	27716010	09/08/2025	NYSE
Common	Brown Brothers Harriman & Co. 140 Broadway New York NY 10005	258287	2396903.36	27716010	09/08/2025	NYSE
Common	TD Bank, N.A. 1701 Route 70 East Cherry Hill NJ 08003	258287	2396903.36	27716010	09/08/2025	NYSE
Common	The Bank of New York Mellon Corporation 240 Greenwich Street New York NY 10286	258287	2396903.36	27716010	09/08/2025	NYSE
Common	JP Morgan Chase Bank, N.A. 270 Park Avenue New York NY 10017	258287	2396903.36	27716010	09/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/22/2018	Shares purchase in the open market at prevailing market price	Various unaffiliated third party brokers			258287	01/22/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Saba Capital Management, L.P. 405 Lexington Avenue, 58th Floor New York NY 10174	Common	06/16/2025	21563	194081.27
Saba Capital Management, L.P. 405 Lexington Avenue, 58th Floor New York NY 10174	Common	06/17/2025	6250	56323.50
Saba Capital Management, L.P. 405 Lexington Avenue, 58th Floor New York NY 10174	Common	09/08/2025	22029	203673.53

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in the SABA Form 144 filing?

The filing reports a proposed sale of 258,287 common shares to be executed on 09/08/2025 on the NYSE through multiple broker-dealers.

When and how were the shares to be sold acquired?

The shares were acquired on 01/22/2018 via open-market purchases and paid for in cash.

Which broker-dealers are named to execute the sale?

Named brokers include Fidelity Capital Markets, FBN Securities, Barclays, BTIG, CIBC Capital Markets, Goldman Sachs, Northern Trust, Brown Brothers Harriman, TD Bank, BNY Mellon, and JP Morgan Chase.

Were there any recent sales by the same account?

Yes. The filing lists sales of 21,563 shares on 06/16/2025, 6,250 shares on 06/17/2025, and 22,029 shares on 09/08/2025 with gross proceeds shown for each.

What representation does the seller make regarding material information?

By signing, the seller represents they do not know any material adverse information about the issuer that has not been publicly disclosed.